FloegeJ., KettelerM.Beta 2-microglobulin-derived amyloidosis: An update. Kidney Int2001; 78(suppl): S164–71.
10.
BardinT., Lebail-DarneJ.L., ZingraffJ.Dialysis arthropathy: Outcome after renal transplantation. Am J Med1995; 99: 243–8.
11.
DiRaimondoC.R., CaseyT.T., Di RaimondoC.V., StoneW.J.Pathologic fractures associated with idiopathic amyloidosis of bone in chronic hemodialysis patients. Nephron1986; 43: 22–7.
12.
PuchtlerH., SweatF., LevineM.On the binding of congo red by amyloid. J Histochem Cytochem1962; 10: 335.
13.
CoggiE., MaioranoE., BraidottiP., Dell'OrtoP., VialeG.Beta-2 microglobulin amyloidosis in synovial membranes: Histopathology, immunocytochemistry and electron microscopy. In: GejyoF., BrancaccioD., BardinT., eds. Dialysis amylodoisis.Milano: Wichtig Editore, 1989, p. 57.
14.
GejyoF., HommanN., SaitoH., ArakawaM.Carpal tunnel syndrome and beta-2 microglobulin amyloidosis: Histological and biochemical aspects, eds. Dialysis amylodoisis. In: GejyoF., BrancaccioD., BardinT., eds. Milano: Wichtig Editore, 1989, p. 35.
15.
GejyoF., HommaN., SuzukiY., ArakawaM.Serum levels of beta 2-microglobulin as a new form of amyloid protein in patients undergoing long-term hemodialysis. N Engl J Med1986; 314: 585–6.
16.
BommerJ., SeeligP., SeeligR., GeerlingsW., BommerG., RitzE.Determinants of plasma beta 2 microglobulin concentration: possible relation to membrane biocompatibility. Nephrol Dial Transplant1987; 2: 22–5.
17.
CanaudB., AssoungaA., FlavierJ.L.Beta-2 microglobulin serum levels in maintenance dialysis. What does it mean? ASAIO Trans1988; 34: 923–9.
18.
SethiD., GowerP.E.Dialysis arthropathy, beta 2-microglobulin and the effect of dialyser membrane. Nephrol Dial Transplant1988; 3: 768–72.
19.
CharraB., CalemardE., LaurentG.Chronic renal failure treatment duration and mode: Their relevance to the late dialysis periarticular syndrome. Blood Purif1988; 6: 117–24.
20.
SchaefferJ., EhlerdingG., FlogeJ., KochK.M., ShaldonS.Beta 2-microglobulin amyloidosis: why and how to look for it. Clin Nephrol1995; 44(suppl 1): S3–9.
21.
CobbyM.J., AdlerR.S., SwartzR., MartelW.Dialysis-related amyloid arthropathy: MR findings in four patients. Am J Roentgenol1991; 157: 1023–7.
22.
JadoulM., MalghemJ., vande BergB., van Ypersele de StrihouC.Ultrasonography of joint capsules and tendons in dialysis-related amyloidosis. Kidney Int1993; 41(suppl): S106–10.
23.
JadoulM., MalghemJ., Vande BergB., van Ypersele de StrihouC.Ultrasonographic detection of thickened joint capsules and tendons as marker of dialysis-related amyloidosis: A cross-sectional and longitudinal study. Nephrol Dial Transplant1993; 8: 1104–9.
24.
GejyoF., YamadaT., OdaniS.A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun1985; 129: 701–6.
25.
GorevicP.D., CaseyT.T., StoneW.J., DiRaimondoC.R., PrelliF.C., FrangioneB.Beta-2 microglobulin is an amyloidogenic protein in man. J Clin Invest1985; 76: 2425–9.
26.
FloegeJ., BurchertW., BrandisA.Imaging of dialysis-related amyloid (AB-amyloid) deposits with 131I-beta 2-microglobulin. Kidney Int1990; 38: 1169–76.
27.
GejyoF., KazamaJ.J., HasegawaS., NishiS., ArakawaM., OdanoI.131I-beta 2-microglobulin scintigraphy in patients with dialysis amyloidosis. Clin Nephrol1995; 44(suppl 1): S14–8.
28.
SchafferJ., BurchertW., FloegeJ.Recombinant versus natural human 111In-beta 2-microglobulin for scintigraphic detection of beta 2-m amyloid in dialysis patients. Kidney Int2000; 58: 873–80.
29.
GejyoF., OdaniS., YamadaT.Beta 2-microglobulin: A new form of amyloid protein associated with chronic hemodialysis. Kidney Int1986; 30: 385–90.
30.
LinkeR.P., HamplH., LobeckH.Lysine-specific cleavage of beta 2-microglobulin in amyloid deposits associated with hemodialysis. Kidney Int1989; 36: 675–81.
31.
MiyataT., IidaY., UedaY.Monocyte/macrophage response to beta 2-microglobulin modified with advanced glycation end products. Kidney Int1996; 49: 538–50.
32.
MiyataT., OdaO., InagiR.Beta 2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest1993; 92: 1243–52.
33.
MiyataT., JadoulM., KurokawaK., Van Ypersele de StrihouC.Beta-2 microglobulin in renal disease. J Am Soc Nephrol1998; 9: 1723–35.
34.
NangakuM., MiyataT., KurokawaK.Pathogenesis and management of dialysis-related amyloid bone disease. Am J Med Sci1999; 317: 410–5.
35.
MiyataT., InagiR., IidaY.Involvement of beta 2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis. Induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-alpha and interleukin-1. J Clin Invest1994; 93: 521–8.
36.
MiyataT., HoriO., ZhangJ.The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta 2-microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyloidosis. J Clin Invest1996; 98: 1088–94.
37.
HouF.F., JiangJ.P., GuoJ.Q.Receptor for advanced glycation end products on human synovial fibroblasts: Role in the pathogenesis of dialysis-related amyloidosis. J Am Soc Nephrol2002; 13: 1296–306.
38.
MoeS.M., HackB.K., CummingsS.A., SpragueS.M.Role of IL-1 beta and prostaglandins in beta 2-microglobulin-induced bone mineral dissolution. Kidney Int1995; 47: 587–91.
39.
PetersenJ., KangM.S.In vivo effect of beta 2-microglobulin on bone resorption. Am J Kidney Dis1994; 23: 726–30.
40.
GarbarC., JadoulM., NoelH., van Ypersele de StrihouC.Histological characteristics of sternoclavicular beta 2-microglobulin amyloidosis and clues for its histogenesis. Kidney Int1999; 55: 1983–90.
41.
AthanasouN.A., AyersD., RaineyA.J., OliverD.O., DuthieR.B.Joint and systemic distribution of dialysis amyloid. Q J Med1991; 78: 205–14.
ChanardJ.Prevention of dialysis-related amyloidosis using the polyacrylonitrile AN69 membrane. Contrib Nephrol1995; 112: 137–44.
45.
KodaY., NishiS., MiyazakiS.Switch from conventional to high-flux membrane reduces the risk of carpal tunnel syndrome and mortality of hemodialysis patients. Kidney Int1997; 52: 1096–101.
46.
LeypoldtJ.K., CheungA.K., DeeterR.B.Effect of dialyzer reuse: Dissociation between clearances of small and large solutes. Am J Kidney Dis1998; 32: 295–301.
47.
RoncoC., BrendolanA., WinchesterJ.F.First clinical experience with an adjunctive hemoperfusion device designed specifically to remove beta 2-microglobulin in hemodialysis. Blood Purif2001; 19: 260–3.
48.
SuzukiK., ShimazakiM., KutsukiH.Beta 2-microglobulin-selective adsorbent column (Lixelle) for the treatment of dialysis-related amyloidosis. Therap Apher Dial2003; 7: 104–7.
